BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Robotin M, Patton Y, Kansil M, Penman A, George J. Cost of treating chronic hepatitis B: Comparison of current treatment guidelines. World J Gastroenterol 2012; 18(42): 6106-6113 [PMID: 23155339 DOI: 10.3748/wjg.v18.i42.6106]
URL: https://www.wjgnet.com/1007-9327/full/v18/i42/6106.htm
Number Citing Articles
1
Camila Lucas de Souza, Thaís de Arvelos Salgado, Tatiana Luciano Sardeiro, Hélio Galdino Junior, Alexander Itria, Anaclara Ferreira Veiga Tipple. Post-vaccination anti-HBs testing among healthcare workers: More economical than post-exposure management for Hepatitis BRevista Latino-Americana de Enfermagem 2020; 28 doi: 10.1590/1518-8345.3534.3278
2
Monica C Robotin, Melanie Q Kansil, Mamta Porwal, Andrew G Penman, Jacob George. Community-based prevention of hepatitis-B-related liver cancer: Australian insightsBulletin of the World Health Organization 2014; 92(5): 374 doi: 10.2471/BLT.13.130344
3
Giuseppe La Torre, Alice Mannocci, Rosella Saulle, Vittoria Colamesta, Angela Meggiolaro, Daniele Mipatrini, Alessandra Sinopoli. Economic evaluation of HBV vaccination: A systematic review of recent publications (2000–2013)Human Vaccines & Immunotherapeutics 2016; 12(9): 2299 doi: 10.1080/21645515.2016.1166328
4
Gaurav Deshpande, Andrew J. Klink, Rahul Shenolikar, Joseph Singer, Debra F. Eisenberg Lawrence, Girishanthy Krishnarajah. Economic burden of hepatitis B infection among patients with diabetesHuman Vaccines & Immunotherapeutics 2016; 12(5): 1132 doi: 10.1080/21645515.2015.1127488
5
Kaviya Chella Pandi, Poongodi Santhana Kumarasamy. Does Hepatitis B Virus DNA Forecast Chronic Hepatitis in Hepatitis B Surface Antigen-positive Patients?Apollo Medicine 2024; 21(2): 117 doi: 10.4103/am.am_182_23